| Literature DB >> 26421658 |
Ana Beatriz W Marcos1, Stefania Forner2, Alessandra C Martini2, Eliziane S Patrício2, Julia R Clarke3, Robson Costa3, João Felix-Alves2, Vilberto José Vieira1, Edinéia Lemos de Andrade2, Tânia Longo Mazzuco4, João Batista Calixto2, Claudia Pinto Figueiredo3.
Abstract
Spinal cord injury (SCI) results in loss of movement, sensibility, and autonomic control at the level of the lesion and at lower parts of the body. Several experimental strategies have been used in attempts to increase endogenous mechanisms of neuroprotection, neuroplasticity, and repair, but with limited success. It is known that glucose-dependent insulinotropic peptide (GIP) and its receptor (GIPR) can enhance synaptic plasticity, neurogenesis, and axonal outgrowth. However, their role in the injury has never been studied. The aim of this study was to evaluate the changes in expression levels of both GIP and GIPR in acute and chronic phases of SCI in rats. Following SCI (2 to 24 h after damage), the rat spinal cord showed a lesion in which the epicenter had a cavity with hemorrhage and necrosis. Furthermore, the lesion cavity also showed ballooned cells 14 and 28 days after injury. We found that SCI induced increases in GIPR expression in areas neighboring the site of injury at 6 h and 28 days after the injury. Moreover, higher GIP expression was observed in these regions on day 28. Neuronal projections from the injury epicenter showed an increase in GIP immunoreactivity 24 h and 14 and 28 days after SCI. Interestingly, GIP was also found in progenitor cells at the spinal cord canal 24 h after injury, whereas both GIP and GIPR were present in progenitor cells at the injury epicenter 14 days after in SCI animals. These results suggest that GIP and its receptor might be implicated with neurogenesis and the repair process after SCI.Entities:
Keywords: glucose-dependent insulinotropic peptide (GIP); glucose-dependent insulinotropic peptide receptor (GIPR); nestin-positive cells; spinal cord injury (SCI)
Mesh:
Substances:
Year: 2015 PMID: 26421658 PMCID: PMC4744885 DOI: 10.1089/neu.2015.3877
Source DB: PubMed Journal: J Neurotrauma ISSN: 0897-7151 Impact factor: 5.269